S&P 500   5,106.36 (-0.48%)
DOW   38,845.35 (-0.37%)
TSLA   182.51 (-2.99%)
NVDA   858.32 (+0.70%)
BABA   71.30 (-0.97%)
T   16.97 (+1.01%)
F   12.70 (-0.31%)
MU   94.08 (-1.76%)
GE   160.56 (-0.28%)
DIS   113.29 (-0.35%)
PFE   25.95 (+0.23%)
PYPL   59.32 (-1.10%)
XOM   103.99 (-0.35%)
S&P 500   5,106.36 (-0.48%)
DOW   38,845.35 (-0.37%)
TSLA   182.51 (-2.99%)
NVDA   858.32 (+0.70%)
BABA   71.30 (-0.97%)
T   16.97 (+1.01%)
F   12.70 (-0.31%)
MU   94.08 (-1.76%)
GE   160.56 (-0.28%)
DIS   113.29 (-0.35%)
PFE   25.95 (+0.23%)
PYPL   59.32 (-1.10%)
XOM   103.99 (-0.35%)
S&P 500   5,106.36 (-0.48%)
DOW   38,845.35 (-0.37%)
TSLA   182.51 (-2.99%)
NVDA   858.32 (+0.70%)
BABA   71.30 (-0.97%)
T   16.97 (+1.01%)
F   12.70 (-0.31%)
MU   94.08 (-1.76%)
GE   160.56 (-0.28%)
DIS   113.29 (-0.35%)
PFE   25.95 (+0.23%)
PYPL   59.32 (-1.10%)
XOM   103.99 (-0.35%)
S&P 500   5,106.36 (-0.48%)
DOW   38,845.35 (-0.37%)
TSLA   182.51 (-2.99%)
NVDA   858.32 (+0.70%)
BABA   71.30 (-0.97%)
T   16.97 (+1.01%)
F   12.70 (-0.31%)
MU   94.08 (-1.76%)
GE   160.56 (-0.28%)
DIS   113.29 (-0.35%)
PFE   25.95 (+0.23%)
PYPL   59.32 (-1.10%)
XOM   103.99 (-0.35%)
OTCMKTS:SNWV

SANUWAVE Health (SNWV) Stock Price, News & Analysis

$0.02
0.00 (0.00%)
(As of 03/4/2024 ET)
Today's Range
$0.02
$0.03
50-Day Range
$0.01
$0.03
52-Week Range
$0.00
$0.04
Volume
83,300 shs
Average Volume
334,248 shs
Market Capitalization
$26.35 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

SNWV stock logo

About SANUWAVE Health Stock (OTCMKTS:SNWV)

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's pulsed acoustic cellular expression systems, including dermaPACE system for treating diabetic foot ulcers and other chronic wounds; orthoPACE system for treating tendinopathies and acute and nonunion fractures; and Profile is used to provide therapeutic treatment of musculoskeletal conditions. Its portfolio of wound treatment solutions provides patients with a noninvasive technology that boosts the body's normal healing and tissue regeneration processes. In addition, the company offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds. SANUWAVE Health, Inc. was founded in 2004 and is headquartered in Eden Prairie, Minnesota.

SNWV Stock Price History

SNWV Stock News Headlines

This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
SANUWAVE Announces Q2 2023 Financial Results
SANUWAVE Health appoints CEO
See More Headlines
Receive SNWV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SANUWAVE Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/16/2020
Today
3/05/2024
Next Earnings (Estimated)
4/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
OTCMKTS:SNWV
Employees
38
Year Founded
N/A

Profitability

Net Income
$-10,290,000.00
Net Margins
-276.15%
Pretax Margin
-263.12%

Debt

Sales & Book Value

Annual Sales
$16.74 million
Book Value
($0.07) per share

Miscellaneous

Outstanding Shares
1,140,560,000
Free Float
953,507,000
Market Cap
$26.35 million
Optionable
Not Optionable
Beta
1.02
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Morgan C. Frank (Age 51)
    CEO & Chairman
    Comp: $43k
  • Mr. Kevin A. Richardson II (Age 56)
    Chief Strategic Officer & Director
    Comp: $605.58k
  • Mr. Andrew Walko (Age 39)
    President
  • Dr. Toni Rinow M.B.A. (Age 59)
    Ph.D., Chief Financial Officer
  • Mr. Peter Stegagno (Age 64)
    Chief Operation Officer
    Comp: $247.83k
  • Dr. Iulian Cioanta (Age 61)
    Chief Science & Technology Officer
    Comp: $233.68k
  • Mr. Tim Hendricks
    Executive VP of Sales for U.S. Wound Business














SNWV Stock Analysis - Frequently Asked Questions

How have SNWV shares performed in 2024?

SANUWAVE Health's stock was trading at $0.0130 at the beginning of 2024. Since then, SNWV stock has increased by 77.7% and is now trading at $0.0231.
View the best growth stocks for 2024 here
.

When is SANUWAVE Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, April 1st 2024.
View our SNWV earnings forecast
.

How were SANUWAVE Health's earnings last quarter?

SANUWAVE Health, Inc. (OTCMKTS:SNWV) issued its earnings results on Monday, November, 16th. The company reported ($0.02) earnings per share for the quarter, missing the consensus estimate of ($0.01) by $0.01. The firm earned $1.97 million during the quarter.

What guidance has SANUWAVE Health issued on next quarter's earnings?

SANUWAVE Health updated its fourth quarter 2023 earnings guidance on Tuesday, January, 30th. The company provided EPS guidance of for the period. The company issued revenue guidance of $6.6 million-$6.8 million.

What other stocks do shareholders of SANUWAVE Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SANUWAVE Health investors own include Co-Diagnostics (CODX), iBio (IBIO), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), Digital Ally (DGLY), Inpixon (INPX), Kopin (KOPN), T2 Biosystems (TTOO) and VBI Vaccines (VBIV).

How do I buy shares of SANUWAVE Health?

Shares of SNWV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:SNWV) was last updated on 3/5/2024 by MarketBeat.com Staff